M&A Snapshot: Novartis to buy Tourmaline Bio for $1.4B, citing promise of heart drug pacibekitug M&A Snapshot: Novartis to buy Tourmaline Bio for $1.4B, citing promise of heart drug pacibekitug Post Contentnvs, trmlRead More You might also be interested in reading Chainlink (ticker: LINK) weekly roundup. September 9, 2025 In Mainstream ← Previous post Next post →